Rashtriya Newsflash

QRCodeStack adds GS1 Digital Link QR codes as retail prepares for Sunrise 2027

QRCodeStack adds GS1 Digital Link QR codes as retail prepares for Sunrise 2027

The QRCodeStack GS1 Digital Link builder encoding a GTIN, batch number and expiry date into one QR code. QRCodeStack now generates GS1 Digital Link QR codes built to URI Syntax

Read Full Article

Obesity Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Merck, Alizyme, Bayer, GlaxoSmithKline, Bristol-Myers Squibb, Currax Pharma, F. Hoffmann-La Roche

(Albany, New York) – September 28, 2026: As per DelveInsight’s assessment, globally, Obesity pipeline constitutes 80+ key companies continuously working towards developing 100+ Obesity treatment therapies, analysis of Clinical Trials,

Read Full Article

Diabetic Macular Edema Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2034 – DelveInsight | Genentech, Novartis, Bayer, Regeneron Pharma, Santen, Kodiak Sciences

The Key Diabetic Macular Edema Companies in the market include – Surrozen, AskGene Pharma, Inc., Therini Bio Pty Ltd, Innovent Biologics Technology Limited, Kodiak sciences, Oculis, Eluminex BioSciences, Ocugen, Innovent

Read Full Article

Vitiligo Market Forecast 2034: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Pfizer, Clinuvel, Inc., Clinuvel Pharma, Bioniz Therapeutics, TAGCyx Biotech

The Key Vitiligo Companies in the market include – Incyte, Abbvie, Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotechnologies, Temprian Therapeutics, Aclaris Therapeutics, TWi Biotechnology, Dermavant Sciences, Amgen, Pfizer,

Read Full Article

Nephrotic Syndrome Market Outlook 2036: Growth Trends, Competitive Landscape, and Future Opportunities – DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharma

The Key Nephrotic Syndrome Companies in the market include – GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers

Read Full Article

Alpha-1 Antitrypsin Deficiency Market Set for Robust Growth Driven by Innovation and Pipeline Advances by 2036 – DelveInsight | Grifols, Kamada Pharma, Takeda, Arrowhead Pharma, Mereo BioPharma

The Key Alpha-1 Antitrypsin Deficiency Companies in the market include – Grifols, Kamada Pharmaceuticals, Takeda, Arrowhead Pharmaceuticals, Mereo BioPharma, AstraZeneca,

Read Full Article

YouTube banned for under-16s in Australia: WhitelistVideo briefing for parents

Illustrative image: how parents can still control what kids watch: An Australian father approving YouTube channels on his phone while

Read Full Article

Myositis Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Myositis Clinical Trials analysis report delivers important insights into ongoing research on 40+ pipeline Myositis Drugs, clinical strategies, upcoming

Read Full Article

Desmoid Tumors Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 4+ Leading Players Wheeling the Therapeutics Landscape

The Desmoid Tumors Clinical Trials analysis report delivers important insights into ongoing research of 4+ pipeline Desmoid Tumors drugs, clinical

Read Full Article

The HABP Therapeutics Market Size is anticipated to grow with a significant CAGR by 2036 | DelveInsight

The HABP Market focuses on the development, adoption, and commercialization of diagnostic solutions, antibiotics, and novel therapies for the management

Read Full Article